ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 126 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $48,000 | -94.1% | 16,705 | -84.2% | 0.00% | -90.2% |
| Q1 2016 | $816,000 | +388.6% | 105,648 | +460.9% | 0.04% | +583.3% |
| Q2 2015 | $167,000 | -85.1% | 18,835 | -83.4% | 0.01% | -87.2% |
| Q1 2015 | $1,121,000 | -90.9% | 113,704 | -88.7% | 0.05% | -87.9% |
| Q4 2014 | $12,301,000 | +2024.5% | 1,004,187 | +1632.2% | 0.39% | +1668.2% |
| Q3 2014 | $579,000 | -61.5% | 57,971 | -87.2% | 0.02% | -77.1% |
| Q4 2013 | $1,505,000 | +2.8% | 453,380 | -6.5% | 0.10% | +1.1% |
| Q3 2013 | $1,464,000 | – | 484,879 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $57,396,000 | 7.04% |
| HealthInvest Partners AB | 497,807 | $2,096,000 | 3.21% |
| BVF INC/IL | 3,285,400 | $13,832,000 | 2.35% |
| EMORY UNIVERSITY | 486,438 | $2,048,000 | 1.93% |
| Marcus Capital, LLC | 69,400 | $1,751,000 | 1.63% |
| DAFNA Capital Management LLC | 196,500 | $827,000 | 0.70% |
| Orbimed Advisors | 13,107,200 | $55,181,000 | 0.62% |
| Rock Springs Capital Management LP | 1,500,000 | $6,315,000 | 0.36% |
| Spark Investment Management LLC | 710,100 | $2,989,000 | 0.19% |
| TURNER INVESTMENTS LLC | 65,420 | $275,000 | 0.18% |